Wise, the UK-headquartered international payments company, is preparing to resubmit its application for a United States bank charter after the Office of the Comptroller of the Currency (OCC) rejected its bid this week, citing concerns over anti-money laundering and countering the financing of terrorism (AML/CFT) compliance risks. The denial — and Wise's stated intention to reapply under the framework of the recently enacted GENIUS Act — throws into sharp relief a tension at the heart of US financial regulation: who, exactly, qualifies for the privilege of a federal banking license in 2026?
The OCC's decision lands with particular force given the context surrounding it. Over the past year, the same regulator has granted comparable charter approvals to a number of digital asset companies — firms operating in a sector that, by any conventional regulatory calculus, carries AML/CFT exposure at least as complex as that of a cross-border payments specialist with Wise's operational history. That apparent asymmetry has prompted immediate questions about whether the OCC is applying its risk standards consistently, or whether Wise, as a foreign-domiciled entity, faces a structurally higher bar regardless of its compliance record.
A Company Built on Cross-Border Complexity
Wise's business model is premised on moving money across borders cheaply and transparently — a proposition that has earned it tens of millions of customers globally and a publicly listed valuation on the London Stock Exchange. That same cross-border architecture, however, is precisely the terrain that AML/CFT regulators scrutinize most intensely. Correspondent banking relationships, multi-currency flows, and customers distributed across high-risk jurisdictions are inherent features of the international remittance business, not aberrations. The OCC's concerns, taken at face value, are therefore not implausible — but neither are they unique to Wise.
What makes the rejection sting more acutely is that Wise has operated under regulated status in multiple major jurisdictions, including authorization from the UK's Financial Conduct Authority (FCA) and licensing across the European Union, the United States at the state level, and several other markets. The company is no regulatory novice navigating unfamiliar compliance terrain. It has built its infrastructure — and its public market credibility — on demonstrating that high-volume cross-border payments can be delivered within robust regulatory frameworks. A federal charter denial on AML/CFT grounds therefore carries reputational weight that Wise's leadership will be keen to contest quickly and publicly.
The GENIUS Act as a New Battleground
Wise's decision to resubmit under the GENIUS Act framework is strategically significant. The GENIUS Act, which has reshaped the legislative landscape for stablecoin issuers and payments-focused financial institutions in the United States, provides an updated regulatory pathway that some argue is better suited to non-traditional financial entities seeking federal recognition. By anchoring its reapplication to this framework, Wise is signaling that it views the legislative environment as having shifted in its favor, even if the OCC's administrative posture has not yet caught up.
The move also places Wise in an interesting competitive position relative to stablecoin issuers and crypto-native firms that have successfully navigated OCC charter approvals in recent months. If the GENIUS Act is broad enough to accommodate digital asset companies with comparable or greater AML/CFT complexity, Wise's legal team will almost certainly argue that a payments company with a decade-long regulated track record deserves at minimum equivalent treatment. That argument has intuitive force, and it is the kind of argument that tends to attract congressional attention when regulatory inconsistency becomes publicly visible.
Regulatory Asymmetry and Its Consequences
The broader implications of this episode extend well beyond Wise. The OCC's willingness to grant federal charters to digital asset companies while denying one to an established, FCA-regulated cross-border payments firm raises legitimate questions about the coherence of US banking regulation at a moment when the sector is undergoing its most consequential structural transformation in decades. If charter approvals are perceived to follow political currents rather than risk-calibrated standards, the credibility of the federal licensing process itself comes under strain.
For foreign-headquartered fintech companies watching this case, the message is sobering: regulatory authorization in your home market, however rigorous, does not translate automatically into a US federal license. The OCC applies its own sovereign framework, and AML/CFT concerns — real or perceived — remain a powerful lever for denial. Wise's reapplication under the GENIUS Act will be watched closely by every international payments firm with US ambitions, because the outcome will effectively set a precedent for how the post-GENIUS Act regulatory architecture treats non-domestic applicants.
Wise has made clear it has no intention of retreating from the US market. The resubmission plan suggests confidence that the legal and regulatory arguments in its favor are strong enough to withstand further scrutiny — and that the GENIUS Act provides the procedural vehicle to make that case compellingly. Whether the OCC agrees will define not just Wise's American future, but the rules of engagement for an entire generation of cross-border fintech entrants.
Written by the editorial team — independent journalism powered by Codego Press.
Top comments (0)